News and features
Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
Existing breast cancer drug offers new targeted treatment for triple negative breast cancer
An already approved breast cancer drug could bring hope to thousands of UK women who have an aggressive form of breast cancer, new research has found.
Promising new treatment strategy for men with drug-resistant prostate cancer
A new experimental drug could offer a promising approach to treating men with advanced prostate cancer which does not respond to existing treatments, or develops resistance to them, researchers report.
Study sheds light on genetic basis of Black men’s higher prostate cancer risk
Black men are more likely than their White or Asian counterparts to have a range of genetic changes that increase their risk of developing prostate cancer, a major new study reports.
The BRCA2 team: Researchers behind the breast cancer gene discovery
25 years ago, ICR researchers made a historic discovery. Juanita Bawagan recounts some of their stories.
New collaboration to advance cancer prevention research and strategies
A new unit focusing on cancer prevention research and strategies has launched at The Institute of Cancer Research, London, and Imperial College London.
New 3D structure could be ‘a treasure map’ guiding search for new treatments
Scientists have created a three-dimensional map of a complex of molecules that plays a fundamental role in life – and which when it goes wrong is linked to increased sensitivity to viral infections and neurodegenerative diseases.
Symphony finished to mark new era for cancer drug discovery
The ICR and Royal Philharmonic Orchestra complete the ‘unfinished symphony’ – to mark the opening of a revolutionary new research centre and a new era for cancer treatment.
-being-attacked-by-two-cytotoxic-t-cells-(red)-547x410.tmb-hbmobile.png?Culture=en&sfvrsn=8f59440b_2 "Immunotherapy - Oral squamous cancer cell (white) being attacked by two cytotoxic T cells (red) 547x410")
Researchers target thyroid cancer with triple threat drug combination
Combining a genetically targeted drug, a cancer-bursting virus and a drug that removes the immune system’s brake pedal can tackle thyroid cancer with newfound gusto, research has found.
Scientific achievements of 2020
We've selected a range of discoveries from 2019/20 – chosen because they illustrate the quality and breadth of our basic, translational and clinical research and our ambitions under the ICR's research strategy.
Actor Eddie Redmayne guest stars in virtual Carols from Chelsea service
We celebrate the festive season and our world-leading research, with a special virtual Carols from Chelsea concert. For the past 17 years, our flagship annual social and fundraising event has been held at The Royal Hospital Chelsea, but is now shared online for the very first time.
Pandemic to delay cancer advances by nearly 18 months, researchers fear
A survey of more than 200 researchers details impact of the pandemic. The scientists estimate their own research has been put back by six months through loss of access to labs, facilities, trials and samples. But they feel science has now adapted to COVID-19 – and researchers believe donations and Government support could accelerate recovery.
‘Molecular clock’ blood test could track spread of breast cancer
A blood test to watch breast cancer’s ‘molecular clock’ could help track the growth of multiple tumours around the body and monitor how they are responding to treatment, new research suggests.
